BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30049632)

  • 1. β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties.
    Jin Y; Li P; Wang F
    Vaccine; 2018 Aug; 36(35):5235-5244. PubMed ID: 30049632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific differences in β-glucan recognition and signalling in porcine innate immune cells.
    Baert K; Sonck E; Goddeeris BM; Devriendt B; Cox E
    Dev Comp Immunol; 2015 Jan; 48(1):192-203. PubMed ID: 25453580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-glucans on the immune system.
    Akramiene D; Kondrotas A; Didziapetriene J; Kevelaitis E
    Medicina (Kaunas); 2007; 43(8):597-606. PubMed ID: 17895634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen.
    Donadei A; Gallorini S; Berti F; O'Hagan DT; Adamo R; Baudner BC
    Mol Pharm; 2015 May; 12(5):1662-72. PubMed ID: 25867449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Interactions of β-(1→3)-Glucans with Their Receptors.
    Legentil L; Paris F; Ballet C; Trouvelot S; Daire X; Vetvicka V; Ferrières V
    Molecules; 2015 May; 20(6):9745-66. PubMed ID: 26023937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity induced by fungal β-glucans via dectin-1 signaling pathway.
    Lee DH; Kim HW
    Int J Med Mushrooms; 2014; 16(1):1-16. PubMed ID: 24940900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.
    Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL
    J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
    Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
    Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory properties and antitumor activities of glucans (Review).
    Vannucci L; Krizan J; Sima P; Stakheev D; Caja F; Rajsiglova L; Horak V; Saieh M
    Int J Oncol; 2013 Aug; 43(2):357-64. PubMed ID: 23739801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR study of short β(1-3)-glucans provides insights into the structure and interaction with Dectin-1.
    Hanashima S; Ikeda A; Tanaka H; Adachi Y; Ohno N; Takahashi T; Yamaguchi Y
    Glycoconj J; 2014 Apr; 31(3):199-207. PubMed ID: 24293021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of soluble β-glucan as an immune stimulant.
    Wu L; Zhao J; Zhang X; Liu S; Zhao C
    Int J Biol Macromol; 2021 May; 179():116-124. PubMed ID: 33667560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal polysaccharides.
    Xiao Z; Zhou W; Zhang Y
    Adv Pharmacol; 2020; 87():277-299. PubMed ID: 32089236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of beta-glucans on porcine leukocytes.
    Sonck E; Stuyven E; Goddeeris B; Cox E
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):199-207. PubMed ID: 20034677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of β-glucans on dendritic cells and implications for cancer therapy.
    Albeituni SH; Yan J
    Anticancer Agents Med Chem; 2013 Jun; 13(5):689-98. PubMed ID: 23092290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
    Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
    J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Glucans and dectin-1.
    Tsoni SV; Brown GD
    Ann N Y Acad Sci; 2008 Nov; 1143():45-60. PubMed ID: 19076344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-glucans as conductors of immune symphonies.
    Dalmo RA; Bøgwald J
    Fish Shellfish Immunol; 2008 Oct; 25(4):384-96. PubMed ID: 18606550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.
    Xiang D; Sharma VR; Freter CE; Yan J
    Curr Med Chem; 2012; 19(25):4298-305. PubMed ID: 22834812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucans and applications in drug delivery.
    Lin H; Han R; Wu W
    Carbohydr Polym; 2024 May; 332():121904. PubMed ID: 38431411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-glucan recognition by the innate immune system.
    Goodridge HS; Wolf AJ; Underhill DM
    Immunol Rev; 2009 Jul; 230(1):38-50. PubMed ID: 19594628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.